Genentech Licenses Sangamo’s DNA-Binding Technology For Protein Production
This article was originally published in The Pink Sheet Daily
Executive SummaryGenentech and Medarex are the only two firms with commercial licenses for the zinc finger DNA-binding protein technology.
You may also be interested in...
The company has reached a broad opioid settlement agreement in principle under which its specialty generics subsidiaries would file for Chapter 11 bankruptcy and Mallinckrodt's branded business would operate separately.